Bacil Pharma Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 0.351 million compared to INR 0.197 million a year ago. Net loss was INR 0.323 million compared to INR 2.487 million a year ago. Basic loss per share from continuing operations was INR 0.05 compared to INR 0.42 a year ago. For the nine months, total revenue was INR 0.758 million compared to INR 1.245 million a year ago. Net loss was INR 0.454 million compared to INR 2.931 million a year ago. Basic loss per share from continuing operations was INR 0.08 compared to INR 0.5 a year ago.